Global Barrett’s Esophagus Market – Industry Trends and Forecast to 2029

Global Barrett’s Esophagus Market, By Type (No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Others), Diagnosis (Endoscopy, Biopsy, Others), Treatment (Medication, Surgery, Others), Route of Administration (Oral, Parenteral, Rectal, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

Market Analysis and Size

Barrett's esophagus is estimated to affect over 12 million adults in the Americas, with over 1.5 million having only been diagnosed. Furthermore, it is expected that approximately 0.5 percent of Barrett's esophagus patients would acquire esophageal cancer. Barrett's esophagus affects more than 10% of people with GERD. Barrett's esophagus has intestinal cells that are more resistant to stomach acid than squamous cells, implying that the tissue alterations occur to protect the esophagus from acid exposure. This disease is more prevalent in men than in women, and it is more common in white people than in Hispanic people. It is uncommon in Asian and black people.

Data Bridge Market Research analyses that the Barrett’s esophagus market was valued at USD 4.43 billion in 2021 and is expected to reach USD 6.50 billion by 2029, registering a CAGR of 4.90% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Barrett's esophagus, often known as gastroesophageal reflux disease (GERD), is a potentially dangerous consequence of GERD. Barrett's esophagus is a condition in which the normal tissue lining the esophagus (the tube that transports food from the mouth to the stomach) transforms into tissue that resembles the gut lining. Barrett's esophagus affects about 10% of those who have GERD symptoms for a long time. Barrett's esophagus has no distinct symptoms, yet patients with Barrett's esophagus may experience GERD symptoms.

Report Scope and Market Segmentation

Barrett’s Esophagus Market Dynamics

Drivers

• Changing lifestyle of people

The continuously changing lifestyle of people is estimated to enhance the Barrett’s esophagus market's growth. Growing obesity rates and increased alcohol consumption, both of which cause GERD in people and lead to Barrett's esophagus, are estimated to propel the market forward. Along with this, growing addiction of smoking is the risk factor resulting in Barrett’s esophagus and hence, influencing the market dynamics during the forecast period of 2022-2029.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of Barrett’s esophagus market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

• Growing number of geriatric population

The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to get Barrett’s esophagus, further estimated to enhance the market’s growth rate.

• Surging incidences of chronic heartburn and acid reflux

The increasing incidences of chronic heartburn and acid refluxis anticipated to influence the growth of Barrett’s esophagus market. Barrett's esophagus is more likely to develop if you have GERD that doesn't improve when you use proton pump inhibitors or if you have GERD that requires daily medication.

Furthermore, rising initiatives by public and private organizations to spread awareness and family history with thyroid diseases will expand the Barrett’s esophagus market. Additionally, rising level of disposable income and increasing number of patients suffering from GERD will result in the expansion of Barrett’s esophagus market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the Barrett’s esophagus market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate. 

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the Barrett’s esophagus market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the Barrett’s esophagus market. Additionally, lack of disease aetiology and low awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This Barrett’s esophagus market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Barrett’s esophagus market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Barrett’s esophagus market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Barrett’s Esophagus Market

Over the projected period, the Barrett’s esophagus market was expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The Barrett’s esophagus market has also been hampered by the supply chain slowness.

Global Barrett’s Esophagus Market Scope

The Barrett’s esophagus market is segmented on the basis of type, treatment, diagnosis, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• No Dysplasia
• Low-Grade Dysplasia
• High Grade Dysplasia
• Others

Treatment

• Medication
• Antacids, proton pump inhibitors
• H2 blockers
• Promotility agents
• Others
• Surgery
• Cryotherapy
• Radiofrequency ablation
• Endoscopic resection
• Others

Diagnosis

• Endoscopy
• Biopsy
• Others

Route of Administration

• Oral
• Rectal
• Parenteral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Barrett’s Esophagus Market Regional Analysis/Insights

The Barrett’s esophagus market is analysed and market size insights and trends are provided by country, type, treatment, diagnosis, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Barrett’s esophagus market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the Barrett’s esophagus market because of the growing prevalence of gastric imbalance diseases as well as obesity and rising healthcare expenditure in this region. Additionally, the presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to rising prevalence of obesity and surging number of generic manufacturers in this region. Also, development of healthcare infrastructure and high alcohol consumption in populated countries will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Barrett’s Esophagus Market Share Analysis

The Barrett’s esophagus market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Barrett’s esophagus market.

Some of the major players operating in the Barrett’s esophagus market are:

• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• Bayer AG (Germany)
• Eli Lilly and Company (US)
• Merck & Co., Inc. (US)
• AstraZeneca (UK)
• Johnson & Johnson Private Limited (US)
• Cipla Inc. (US)
• Abbott (US)
• AbbVie Inc. (US)
• Merck KGaA (Germany)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)
• Dr. Reddy’s Laboratories Ltd. (India)
• Pfizer Inc. (US)
• Sanofi (France)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Boehringer Ingelheim International GmbH. (Germany)
• Procter & Gamble (US)
• Takeda Pharmaceutical Company Limited (Japan)
• Eisai Co., Ltd. (Japan)